B

Blue Bees Therapeutics

Latest funding round: 2 M$

B

• City : Orsay
• Round : Early stage
• Sector : Health

Blue Bees Therapeutics develops cancer immunotherapies, including candidate BB101. They aim to stimulate immune response to better control tumour growth.